Furthermore, Mendelian Randomization (MR) analyses (cf.Methods) of RIPK2 gene expression in the cerebellum and protein abundance in the cortex suggest a potentially causal role for RIPK2 in protecting against AD (Figure 4f). This evidence concerns the gene RIPK2 and Alzheimer disease.